Tony Arulanandam
Company: Synaptimmune Therapeutics
Job title: CEO and Founder
Seminars:
Panel Discussion: Combining Cell Therapies with Synergistic Treatments to Prevent Antigen Escape 2:30 pm
Uncovering combination assets to synergize cell therapies and potentiate anti-tumor response Mitigating against combinatorial toxicities to promote safe tumor regressionRead more
day: Post-Conference Day - Tackling Solid Tumors